OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION

NIH RePORTER · NIH · N01 · $11,811 · view on reporter.nih.gov ↗

Abstract

The project is involved in the analytical assessment of bulk drug substances and clinical drug products of anti-tumor drug candidates. Physical and chemical data provided in the study reports will be submitted as part of the Investigational New Drug (IND) filing required for clinical studies of potential anti-tumor agents.

Key facts

NIH application ID: 10856892
Project number: 261201200028C-P00035-9999-1
Recipient: SRI INTERNATIONAL
Principal Investigator: JENNIE WANG, PH.D.
Activity code: N01
Funding institute: NIH
Fiscal year: 2023
Award amount: $11,811
Award type: —
Project period: 2012-08-01 → 2018-12-31